Congress vs Sebi chief Buch: Trading strategies in M&M, Pidilite, Wockhardt
Source: Business Standard
Mahindra & Mahindra, Pidilite and Dr.Reddy’s became the latest company names to be dragged in the so-called ‘Conflict of Interest’ battle against the Securities and Exchange Board of India (Sebi) chairperson Madhabi Puri Buch by the Congress.
The Congress today claimed that Sebi chief and her husband Dhaval Buch received Rs 4.78 crore between 2019 and 2021 from Mahindra and Mahindra (M&M). A claim clearly denied by the automaker.
M&M denied the allegations as ‘false and misleading”. However, it clarified that Dhaval Buch was hired by Mahindra Group in 2019 “specifically for his expertise in supply chain and sourcing”, after he retired as Unilever’s global chief procurement officer.
“We categorically state that we have not, at any point, requested SEBI for any preferential treatment. We maintain the highest standards of corporate governance,” Mahindra & Mahindra said in an exchange filing.
Against, these multiple controversies, what should your trading strategy be in these stocks. Here’s a trading guide:
Mahindra & Mahindra (M&M)
Current Price: Rs 2,695
Downside Risk: 13.7%
Support: Rs 2,690; Rs 2,629
Resistance: Rs 2,758; Rs 2,781
The key momentum oscillators on the weekly and monthly chart have shown negative crossovers in recent trading days. Hence, the stock may witness downward pressure in the near-term. As such, the stock could dip to Rs 2,326 levels.
The overall bias is likely to remain tepid as long as the stock trades below Rs 2,845, with interim resistance seen at Rs 2,781 and Rs 2,758 levels.
Dr. Reddy’s Lab
Current Price: Rs 6,654
Downside Risk: 8.1%
Support: Rs 6,382
Resistance: Rs 6,752; Rs 6,873; Rs 7,000
For now, the stock seems on course to test its 20-WMA at Rs 6,382 levels; break and sustained trade below the same can trigger a fall towards Rs 6,115. The overall bias is likely to remain tepid as long as the stock trades below Rs 7,000-mark.
Pidilite Industries
Current Price: Rs 3,244
Upside Potential: 4.8%
Support: Rs 3,235; Rs 3,215
Resistance: Rs 3,265; Rs 3,323
On the upside, the stock is trading in unchartered territory, and may look to extend the rally towards Rs 3,400 levels. Near support for the stock is visible at Rs 3,235 and Rs 3,215; below which it may test Rs 3,100 levels.
Wockhardt
Current Price: Rs 1,036
Upside Potential: 16.3%
Support: Rs 1,019; Rs 930
Resistance: Rs 1,110; Rs 1,145; Rs 1,175
Wockhardt Pharma stock is seen testing support around its 20-DMA for the last couple of trading sessions. The stock has zoomed over 383 per cent in the last 11 months. The long-term chart shows that the overall bias for the stock is likely to remain upbeat as long as the stock trades above Rs 1,019 levels; below which support for the stock exists at Rs 930.
First Published: Sep 10 2024 | 3:24 PM IST
